Cargando…
Low Incidence of the DPD IVS14+1G>A Polymorphism in Jordanian Breast and Colorectal Cancer patients
BACKGROUND: Dihydropyrimidine dehydrogenase (DPD) is a crucial enzyme in the catabolism of 5-fluorouracil (5-FU), a drug that is frequently used in cancer therapy. Patients with deficient DPD activity are at risk of developing severe 5-FU–associated toxicity. One possible cause of deficiency is gene...
Autores principales: | Al-Khateeb, Mohammad, Awidi, Abdalla, Al-Hadidi, Kamal, Battah, Abdelkader |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373818/ https://www.ncbi.nlm.nih.gov/pubmed/28670884 http://dx.doi.org/10.22034/APJCP.2017.18.6.1651 |
Ejemplares similares
-
APOE Gene polymorphism among Jordanian Alzheimer’s patients with relation to lipid profile
por: Shafagoj, Yanal A., et al.
Publicado: (2018) -
Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door
por: Donadio, Mauro Daniel Spina, et al.
Publicado: (2022) -
Delayed Presentation of DPD Deficiency in Colorectal Cancer
por: Law, Lindsey, et al.
Publicado: (2014) -
Application of Gas Chromatography–Mass Spectrometry
for the Identification and Quantitation of Three Common Synthetic
Cannabinoids in Seized Materials from the Jordanian Market
por: AL-Eitan, Laith N., et al.
Publicado: (2020) -
Unique Variant Spectrum in a Jordanian Cohort with Inherited Retinal Dystrophies
por: Azab, Bilal, et al.
Publicado: (2021)